“…Since the first attempts to treat genetically based diseases using retroviral vectors to deliver transgenes to host cells, 1 , 2 various non-viral vectors and transgene delivery methods have been developed, including nanoparticle-mediated gene delivery, 3 physical methods, 4 , 5 , 6 plasmids, 7 , 8 , 9 and DNA transposons, which are DNA sequences that can move from one location and become integrated into another locus of the genome. 10 Even though transposons were discovered in the 1950s, it has been shown only recently that the transposon named Sleeping Beauty ( SB ), and especially its hyperactive form ( SB100X ), is able to efficiently and safely integrate transgenes into the host genome, providing sustained transgene expression in quiescent and dividing cells.…”